Tag: Salix PharmaceuticalsSort
CRWE, SLXP, PGNX, HRS - BestOtc.com Stock Report! Crown Equity Holdings, Salix Pharmaceuticals, Progenics Pharmaceuticals, Harri
CHMT, CRWE, SLXP, WDR - PennyToBuck.com Stock News! Chemtura Corporation, Crown Equity Holdings, Salix Pharmaceuticals, Waddell
(CSIQ, PGNX, MSHL, SLXP) PennyOmega.com Stocks In Action
MSHL, Marshall Edwards Inc.
** MSHL reported that the U.S. Patent and Trademark Office has issued a new patent, U.S. Patent No. 8,080,675, covering a number of the Company's isoflavone-based compounds, including lead oncology-drug candidates ME-143 and ME-344, and their pharmaceutical compositions. The patent is estimated to provide protection until March 2027.
MSHL, CSIQ, SLXP, PGNX - CRWESelect.com Stock News! Marshall Edwards, Canadian Solar, Salix Pharmaceuticals, Progenics Pharmaceu
To view video, and read the full article visit URL http://crweselect.com/27851/stock-alerts/mshl-csiq-slxp-pgnx-crweselectc...
Marshall Edwards, Inc. (NASDAQ:MSHL)
(SLXP, TNGO, CLNO, MCHX, LPSN) PennyOtcStock.com Stock Watch!
SLXP, CPTS, CLNO, NRCI, VALV, - CRWESelect.com Stock Highlights! Salix Pharmaceuticals Ltd., Conceptus, Cleantech Transit, Natio
To view video, and read the full article visit URL http://crweselect.com/27275/stock-alerts/slxp-cpts-clno-nrci-valv-crwese...
Salix Pharmaceuticals Ltd. (NASDAQ:SLXP)
SLXP, SONS, CRWE, SMTX, ATHX - NASDAQ News Updates and News From Stock.PR.com
(DARA, MKTG, SLXP) PennyOmega.com Watch List for Wed Nov. 09, 2011
SLXP, Salix Pharmaceuticals, Ltd.
** On its third quarter fiscal 2011 results, SLXP posted total product revenue of $146.2 million, an 81% increase year over year.
SLXP is increasing its estimate of 2011 total product revenue to approximately $535 million, which represents 59% growth over 2010 revenue.